A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Public ClinicalTrials.gov record NCT03574571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Study identification
- NCT ID
- NCT03574571
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 732 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2018 (Actual)
- Primary completion
- Apr 1, 2027 (Estimated)
- Completion
- Apr 1, 2027 (Estimated)
- Last update posted
- May 14, 2026
2018 – 2027
United States locations
- U.S. sites
- 40
- U.S. states
- 23
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Yale University- Yale Cancer Center | New Haven | Connecticut | 06510 | — |
| Helen Graham Cancer Center (Christiana Care) | Newark | Delaware | 19713 | — |
| Boca Raton Regional Hospital | Boca Raton | Florida | 33486 | — |
| Mount Sinai Medical Center (Miami) | Miami | Florida | 33140 | — |
| Rush University Medical Center | Chicago | Illinois | 606012 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Ochsner Cancer Institute | New Orleans | Louisiana | 70121 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| University of Massachusetts | Worcester | Massachusetts | 01655 | — |
| University of Michigan Cancer Center | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68114 | — |
| XCancer Omaha / Urology Cancer Center | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89128 | — |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | — |
| MD Anderson Cancer Center at Cooper | Camden | New Jersey | 08103 | — |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | — |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | — |
| New Jersey Urology | Saddle Brook | New Jersey | 07663 | — |
| New Mexico Oncology and Hematology | Albuquerque | New Mexico | 87109 | — |
| University of Buffalo | Buffalo | New York | 14203 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263-0001 | — |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | — |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| New York Presbyterian Hospital-Weill Medical College of Cornell University | New York | New York | 10065 | — |
| Bronx VA Hospital | New York | New York | 10468 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Atrium Health/ Levine Cancer Institute | Monroe | North Carolina | 28112 | — |
| University of Cincinnati Medical Center | Cincinnati | Ohio | 45219 | — |
| Dayton Physicians Network | Kettering | Ohio | 45409 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Houston Methodist Research Institute | Houston | Texas | 77030 | — |
| Millennium Physicians | Houston | Texas | 77090 | — |
| University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03574571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 14, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03574571 live on ClinicalTrials.gov.